CTS 2026: What to Expect in Las Vegas

Arshad M. Khanani, MD, previews this year’s Clinical Trials at the Summit meeting, highlighting new clinical trial data, expert panels discussing a variety of topics, and a keynote by the former director of the FDA’s ophthalmic devices division.

By Arshad M. Khanani, MD, MA, FASRS

FDA Veteran Shares Insights on Trial Design and Endpoints

Former FDA ophthalmology leader Wiley A. Chambers, MD, discusses pivotal studies, safety databases, and regulatory expectations for retinal therapies.

By Diana V. Do, MD

How to Choose the Right CRO

During a panel discussion at Clinical Trials at the Summit, representatives of sponsors and CROs discussed experience, staffing, costs, and the factors that drive trial performance.

By Jim Gallagher, senior managing editor

LensOne Heads Toward Pivotal Trial

At Clinical Trials at the Summit 2026, Frank Brodie, MD, MBA, reviewed clinical findings for the prosthetic capsular bag and outlined plans for the GOLDEN GATE study.

By Frank Brodie, MD, MBA, Diana V. Do, MD

SPECTRA Data Support 4D-150 in DME

Anat Loewenstein, MD, MHA, discusses previously presented findings from the SPECTRA trial at Clinical Trials at the Summit 2026.